Biomarkers refer to genes, molecules or certain characteristics enabling to evaluate or measure pharmacologic response to therapeutic treatment, or various pathogenic or biological processes. Categorized by their utilization in different medical procedures, biomarkers facilitate decision-taking in early clinical drug development, thus helping to detect a patient’s health state. Oncology belongs within the major diseases where biomarkers are widely used.
Supported by novel product’s introductions, fresh market entrants, as well as M&As and other related activities, the world Biomarkers Market is evolving at a colossal tempo, set to be ultimately valued at just over EUR 26 billion by end-2018. Novel technologies exploited for biomarker discovery are the foremost contributors to the Biomarkers sector. North America heads the market as the most speedily growing geographic area. Major Biomarkers Market participants encompass, among others, Abbot Laboratories, Affymetrix, Agilent, Epigenomics, Celera, GE Healthcare, and DiagnoCure.
The research reports under this MarketPublishers’ Catalogue delve deep into the Biomarkers Market and its major submarkets – discovery technologies, services market, application market, and various indications. Covering various geographies, the research reports identify and examine the principal trends, opportunities, and the factors propelling or clogging the market growth. The competitive landscape with comprehensive profiles of numerous players in the global Biomarkers Industry, forecasts throwing light on the market’s future are provided in the research reports too.
Publications found:
141
Sort by:
Global Cell Surface Markers Detection Market - 2025-2033
US$ 3,400.00
Global Cell Surface Markers Detection Marketis is growing with a CAGR of 8.40% during the forecast period 2026-2035. The Global Cell Surface Markers Detection Market emerges as a key focus in DataM In...
February 2025
63 pages
Biomarkers Market Size, Share, and Analysis, By Type (Safety, Efficacy, and Validation), By Application (Diagnostics Development, Drug Discovery & Development, Personalized Medicine, Disease-Risk Assessment, and Others), By Product Type (Consumables, Services, and Software), By Technology (Safety Biomarkers, Efficacy Biomarkers, and Validation Biomarkers), By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Biomarkers Market Size, Share, and Analysis, By Type (Safety, Efficacy, and Validation), By Application (Diagnostics Development, Drug Discovery & Development, Personalized Medicine, Disease-Risk Asse...
February 2025
573 pages
Biomarkers: Technologies and Global Markets
US$ 4,650.00
... Middle East and Africa Characterization and quantification of the market potential for biomarkers by segment, product type, therapeutic area and geographical ... focus on regulatory development, key technology updates and major drivers impacting the global market Assessment of the leading biotechnology companies ...
January 2025
165 pages
Oxidative Stress Assay Market - 2025-2032
US$ 3,400.00
Oxidative Stress Assay Market reached US$ 1.18 billion in 2024 and is expected to reach US$ 1.9 billion by 2032, growing with a CAGR of 9.70% during the forecast period 2026-2032. The Oxidative Stress...
January 2025
48 pages
Carcinoembryonic Antigen (CEA) Market - 2024-2031
US$ 3,400.00
Carcinoembryonic Antigen (CEA) Marketis is growing with a CAGR of 3.90% during the forecast period 2026-2035. The Carcinoembryonic Antigen (CEA) Market emerges as a key focus in DataM Intelligence lat...
November 2024
56 pages
Renal Biomarkers Market - 2024-2031
US$ 3,400.00
The Renal Biomarkers Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparal...
October 2024
42 pages
Activin A Market - 2024-2031
US$ 3,400.00
Activin A Marketis is growing with a CAGR of 3.80% during the forecast period 2026-2035. The Activin A Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned rese...
June 2024
35 pages
Prostate Cancer Biomarker Market - 2024-2031
US$ 3,400.00
Prostate Cancer Biomarker Marketis is growing with a CAGR of 12.61% during the forecast period 2026-2035. The Prostate Cancer Biomarker Market emerges as a key focus in DataM Intelligence latest in-de...
April 2024
51 pages
Atypical Chemokine Receptor 3 Market - 2024-2031
US$ 3,400.00
The Atypical Chemokine Receptor 3 Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to de...
March 2024
55 pages
Toll Like Receptor 3 Market - 2024-2031
US$ 3,400.00
Toll Like Receptor 3 Marketis is growing with a CAGR of 5.30% during the forecast period 2026-2035. The Toll Like Receptor 3 Market emerges as a key focus in DataM Intelligence latest in-depth analysi...
February 2024
46 pages
Somatostatin Receptor Type 2 Market - 2024-2031
US$ 3,400.00
The Somatostatin Receptor Type 2 Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to del...
February 2024
54 pages
Global Crashworthy Seats Market Growth 2025-2031
US$ 3,660.00
The report requires updating with new data and is sent in 48 hours after order is placed. The global Crashworthy Seats market size is predicted to grow from US$ million in 2025 to US$ million in 2031...
January 2024
93 pages
Cell Viability Assays Market - 2024-2031
US$ 3,400.00
Cell Viability Assays Marketis is growing with a CAGR of 14.00% during the forecast period 2026-2035. The Cell Viability Assays Market emerges as a key focus in DataM Intelligence latest in-depth anal...
January 2024
47 pages
Biomarker Collaboration and Licensing Deals 2016-2023
US$ 3,995.00
SUMMARY Biomarker Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research d...
November 2023
300 pages
Integrin Beta 3 Market - 2024-2031
US$ 3,400.00
The Integrin Beta 3 Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparall...
January 2023
41 pages
Predisposition Biomarkers: Technologies and Global Markets
US$ 3,950.00
REPORT INCLUDES: An overview of technologies and global markets for the predisposition biomarkersAnalyses of the global market trends with data from 2018, estimates for 2019, and projections of compo...
October 2019
72 pages
Asia Pacific Cardiac Biomarkers Testing Market 2019-2025)
US$ 1,500.00
The Asia Pacific Cardiac Biomarkers Testing Market would witness market growth of 12.8% CAGR during the forecast period (2019–2025). Asia Pacific would emerge as ... of the most lucrative regions for Cardiac Biomarkers testing market. Prime factor fueling the growth of Asia Pacific region includes the presence of ...
June 2019
104 pages
Europe Cardiac Biomarkers Testing Market (2019-2025)
US$ 1,500.00
The Europe Cardiac Biomarkers Testing Market would witness market growth of 11.1% CAGR during the forecast period (2019–2025). The ability of cardiac markers for accurate and rapid prediction ...
June 2019
104 pages
Global Cardiac Biomarkers Testing Market (2019-2025)
US$ 3,600.00
The Global Cardiac Biomarkers Testing Market size is expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period. Cardiac biomarkers or cardiac markers are endogenous substances which are ...
June 2019
250 pages
Global Cardiac Biomarkers Market Size study, by type (Myocardial muscle Creatine Kinase, Myoglobin, Troponins (T and I), Ischemia Modified Albumin (IMA), Brain Natriuretic Peptide (BNPs) or NT-proBNP and Others) Application (myocardial infarction, congestive heart failure, acute coronary syndrome, Atherosclerosis, other applications) Location of Testing (point of care testing and laboratory testing) and Regional Forecasts 2018-2025.
US$ 3,750.00
... are responsible for the wide adoption of cardiac biomarkers globally. Global cardiac biomarker market is majorly driven by rising prevalence of cardiovascular ... Target Audience of the Global Cardiac Biomarkers Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises ...
February 2019
200 pages
Global Non-alcoholic Steatohepatitis Biomarkers Market Forecast, 2018-2023
US$ 3,600.00
... government policies impacting the global non-alcoholic steatohepatitis biomarkers market. Insights about market determinants which are stimulating the global non-alcoholic steatohepatitis biomarkers market. Detailed and extensive market segments with regional distribution ...
January 2019
-
Global Multiplex Biomarker Imaging Market (2018–2023)
US$ 2,950.00
... global multiplex biomarker imaging market is projected to expand at a compound annual growth rate (CAGR) of 12.0% during the 2018–2023 period, generating a revenue of USD 523.59 Mn by 2023. The global multiplex biomarker imaging market ... insights: The global multiplex biomarker imaging market can be segmented ...
January 2019
90 pages
Cardiac Biomarkers: Market Research Report
US$ 5,450.00
This report analyzes the worldwide markets for Cardiac Biomarkers in US$ Thousand by the following Testing Locations: Laboratory Testing, and Point of ... 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
July 2018
200 pages
Global Biomarkers Market Analysis & Forecast Report 2017-2022
US$ 2,600.00
The Global Biomarkers Market Analysis & Forecast Report 2017-2022 is a professional and in-depth study on the current state of the Biomarkers Market. The report analysis the global market of Biomarkers by main manufactures and geographic regions. The report includes Biomarkers definitions, classifications, applications and ...
February 2017
105 pages
Global Molecular Biomarkers Industry Analysis & Forecast Market Report 2016-2021
US$ 2,600.00
... Global Molecular Biomarkers Industry Analysis & Forecast Market Report 2016-2021 is a professional and in-depth study on the current state of the Molecular Biomarkers industry. The report analysis the global market of Molecular Biomarkers by main manufactures and geographic regions. The report includes Molecular Biomarkers definitions, classifications, applications ...
October 2016
115 pages
Antibody Target, Technology & Pipeline Database: 1-Year Subscription
US$ 1,600.00
Antibody Target, Technology & Pipeline Database: 1-Year Subscription Therapeutic monoclonal antibodies have become a clinically and commercially successful class of drugs. Branded therapeutic antibodies on the market reached ... of the Antibody Target, Technology & Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase. Benefits from the Antibody Pipeline Database: Intuitive ...
April 2016
-
Research Report on Global and China Monoclonal Antibody Industry, 2013-2017
US$ 2,200.00
... the development of biological drugs in the next few years. In recent years, China bio-pharmaceuticals industry develops rapidly, but antibody drugs lag ... products in the future. Monoclonal antibody still belongs to high-end products in China market, which mainly depends on import. In 2012, the market scale ...
August 2013
50 pages
Biomarkers: Market Research Report
US$ 4,800.00
... and Others (miRNA Analysis and Others). The total market is also analyzed by the following Application Areas: Biomarker Discovery, Clinical Drug Development, and ... , Inc., Rules-Based Medicine, Inc., and Siemens Healthcare Diagnostics, Inc. Market data and analytics are derived from primary and secondary ...
August 2011
1305 pages
China Monoclonal Antibody Industry Report, 2010-2011
US$ 1,700.00
China has been engaging in the R&D of monoclonal antibody industry for a long time, but still lags far behind the European and American countries in terms of industrialization. In 2010, the market...
July 2011
64 pages
Competitor Analysis Antibody Therapy of Inflammatory and Autoimmune Diseases
US$ 1,184.00
Product description The present Competitive Intelligence Report about Antibody Therapy of Inflammatory and Autoimmune Diseases provides a competitor evaluation in the field of antibody therapeutics used or being developed for treatment of rheumatoid arthritis, psoriasis, Crohn’s disease, ulcerative colitis ...
December 2010
172 pages
Global Monoclonal Antibody Market Analysis
US$ 1,200.00
Single User PDF Format: US$ 1,200.00
Multi-User License: US$ 1,600.00
Hard Copy: US$ 1,300.00
CD-ROM: US$ 1,300.00 Considered as an indispensable tool in the clinical and biotechnology...
November 2010
80 pages
Antibody Pipeline Database: 1-Year Subscription
US$ 1,638.00
... numerical order, e.g. for phase, product category or company name. Sample screenshots illustrate the database. Purchase of the subscription provides a 1-year online access to the data of the Antibody Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase. ...
November 2010
-